System and method for cell levitation and monitoring
US-2024361343-A1 · Oct 31, 2024 · US
US9976133B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9976133-B2 |
| Application number | US-201314406999-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 20, 2013 |
| Priority date | Jun 20, 2012 |
| Publication date | May 22, 2018 |
| Grant date | May 22, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Novel synthetic catalytic structures or “synzymes,” e.g., synthetic polypeptides, with catalytic properties are provided. It is believed that these synthetic catalytic structures mimic some of the precise conformational changes necessary for catalytic activities seen in enzymes. The catalytic properties of these synthetic catalytic structures or synzymes can be further improved by the application of controlled external forces, e.g., electric fields.
Opening claim text (preview).
What is claimed is: 1. A synthetic polypeptide comprising an amino acid sequence selected from the group consisting of: (SEQ ID NO: 22) Gly-Ala-Phe-Cys-Phe-His-Ala-Asp; (SEQ ID NO: 23) Gly-Ala-Phe-Ser-Phe-His-Ala-Asp; (SEQ ID NO: 24) Asp-Phe-His-Phe-Cys-Ala-Gly-Asp; (SEQ ID NO: 25) Asp-Phe-His-Phe-Ser-Ala-Gly-Asp; (SEQ ID NO: 26) Gly-Gly-Ala-Ala-Cys-Ala-His-Ala-Asp; (SEQ ID NO: 27) Arg-Gly-Ala-Ala-Cys-Ala-His-Ala-Asp; (SEQ ID NO: 28) Arg-Gly-Ala-Ala-Ser-Ala-His-Ala-Asp; (SEQ ID NO: 29) Arg-Gly-Ala-Phe-Cys-Phe-His-Ala-Asp; (SEQ ID NO: 30) Lys-Gly-Ala-Phe-Cys-Phe-His-Ala-Asp; (SEQ ID NO: 31) Arg-Gly-Ala-Phe-Ser-Phe-His-Ala-Asp; (SEQ ID NO: 32) Lys-Gly-Ala-Phe-Ser-Phe-His-Ala-Asp; (SEQ ID NO: 33) Arg-Asp-Phe-His-Phe-Cys-Ala-Gly-Asp; (SEQ ID NO: 34) Arg-Asp-Phe-His-Phe-Ser-Ala-Gly-Asp; (SEQ ID NO: 36) Arg-Gly-His-Gly-Gly-Pro-Gly-Gly-His- Gly-Cys-Gly-Asp; and (SEQ ID NO: 37) Arg-Gly-Gly-His-Phe-Cys-Gly-Pro-Gly- His-Gly-His-Gly-Asp, and wherein the synthetic polypeptide is from 6 to 30 amino acids total in length. 2. The synthetic polypeptide of claim 1 , wherein the synthetic polypeptide comprises an amino acid sequence selected from the group consisting of: (SEQ ID NO: 26) Gly-Gly-Ala-Ala-Cys-Ala-His-Ala-Asp; (SEQ ID NO: 27) Arg-Gly-Ala-Ala-Cys-Ala-His-Ala-Asp; (SEQ ID NO: 28) Arg-Gly-Ala-Ala-Ser-Ala-His-Ala-Asp; (SEQ ID NO: 29) Arg-Gly-Ala-Phe-Cys-Phe-His-Ala-Asp; (SEQ ID NO: 30) Lys-Gly-Ala-Phe-Cys-Phe-His-Ala-Asp; (SEQ ID NO: 31) Arg-Gly-Ala-Phe-Ser-Phe-His-Ala-Asp; (SEQ ID NO: 32) Lys-Gly-Ala-Phe-Ser-Phe-His-Ala-Asp; (SEQ ID NO: 33) Arg-Asp-Phe-His-Phe-Cys-Ala-Gly-Asp; and (SEQ ID NO: 34) Arg-Asp-Phe-His-Phe-Ser-Ala-Gly-Asp, and wherein the synthetic polypeptide is from 9 to 15 amino acids total in length.
Proteinases, i.e. endopeptidases (3.4.21-3.4.99) · CPC title
Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves · CPC title
Cysteine endopeptidases (3.4.22) · CPC title
having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68) · CPC title
having 5 to 11 amino acids · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.